官方服务：
资源简介：
Elemonic acid inhibits colorectal cancer
应用场景：
创建时间：
2021-08-10
相关数据集
Calcium Electroporation for Early Colorectal Cancer
This is an explorative, phase I clinical trial. The aim of this study is to establish the safety and efficacy of treating patients with early colorectal cancer with calcium electroporation prior to in
NIAID Data Ecosystem80
A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal Cancers
To determine the maximum tolerated dose and dose limiting toxicity of 5-FU and leucovorin with novel 48-hour infusion schedule, and to collect toxicity profile at different dose level of 5-FU/LV 48-ho
NIAID Data Ecosystem60
Kaempferol improves acute kidney injury via inhibition of macrophage infiltration in septic mice
Figure 1- Figure 4 raw data from Xu, et al 2022 Peer journal
NIAID Data Ecosystem50
A multicenter phase II study of FOLFIRI as first-line chemotherapy for metastatic colorectal cancer with reduced starting dose of irinotecan in patients with homozygous for UGT1A1(FLIGHT1)
Interventions: On Day 1, patients treated with FOLFIRI therapy received a 2-hour intravenous infusion of CPT-11 (150 mg/m2) combined with 1-LV (200 mg/m2), followed by a rapid intravenous infusion of
NIAID Data Ecosystem60
Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
This study is designed to compare the efficacy and safety of two-weekly RAILIRI regimen with FOLFIRI regimen in the treatment of advanced colorectal cancer patients in the second-line setting.
NIAID Data Ecosystem50
